New York / New York / United States
Immtech Pharmaceuticals is a pharmaceutical company that advances the development and commercialization of oral drugs to treat infectious diseases and extends its aromatic cation technology platform to the treatment of cancer, diabetes and other diseases. The company has clinical programs that include new treatments for malaria, pneumocystis pneumonia and African sleeping sickness, and drug development programs for fungal infections and tuberculosis. Immtech received worldwide patents and patent applications, and licenses and rights to license technology, primarily from a scientific consortium that has granted the company a worldwide license and rights to commercialize products from, and license rights to, the technology. The scientific consortium includes scientists from the University of North Carolina at Chapel Hill, Georgia State University, Duke University and Auburn University. Immtech Pharmaceuticals is headquartered in Vernon Hills, Ill.
